Trajan Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-62,196
Closed -$5.39M 159
2026
Q1
$5.39M Buy
62,196
+6,018
+11% +$577K 0.22% 86
2025
Q4
$5.4M Buy
56,178
+317
+0.6% +$30.8K 0.22% 76
2025
Q3
$5.32M Sell
55,861
-127
-0.2% -$11.7K 0.23% 73
2025
Q2
$4.88M Buy
55,988
+1,246
+2% +$106K 0.24% 78
2025
Q1
$4.92M Sell
54,742
-4,214
-7% -$377K 0.27% 80
2024
Q4
$4.71M Buy
58,956
+3,767
+7% +$326K 0.26% 79
2024
Q3
$4.97M Buy
55,189
+3,938
+8% +$331K 0.29% 74
2024
Q2
$4.03M Buy
51,251
+1,009
+2% +$82.7K 0.26% 85
2024
Q1
$4.38M Buy
+50,242
New +$4.29M 0.3% 79

Other funds holding MDT

Trajan Wealth's MDT Position: Q2 2026 in Review

Trajan Wealth sold out of Medtronic (MDT) in Q2 2026, closing a stake of 62,196 shares — an estimated $5.39M sold.

Trajan Wealth first reported a position in MDT in Q1 2024 and held it in 9 quarters. The position peaked at $5.4M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Trajan Wealth reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Trajan Wealth sold 62,196 Medtronic shares in Q2 2026, an estimated $5.39M.
  • Trajan Wealth first reported a position in Medtronic in Q1 2024 and held it in 9 quarters.
  • Trajan Wealth's Medtronic position peaked at $5.4M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Trajan Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.